CompletedNCT02382848

Effectiveness of Prazosin in Bulimic Patients Experiencing Nightmares Due to PTSD

It focuses on PTSD and currently lists study information in the United States.

PTSD, Eating disordersDrugFrom 18 Years to 45 Years

The study in practice

Understand this study

This study evaluated the effectiveness of Prazosin for people with PTSD.

Listed age limits: 18 years to 45 years.

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study start dateJuly 2015

Recruitment status: Completed
Enrollment listed in the registry: 9
Sponsor: Milton S. Hershey Medical Center
Sponsor type: Individual investigator
Study type: Drug
Intervention type: Medication / drug
Study phase: Not clearly listed
Locations: United States
Age range: From 18 Years to 45 Years
Official registry ID: NCT02382848
Official title: Effectiveness of Prazosin in Bulimic Patients Experiencing Nightmares Due to PTSD

Completed

Hershey

FAQ

What did researchers investigate?

This study evaluated the effectiveness of Prazosin for people with PTSD.

Who is behind this study?

The study sponsor is Milton S. Hershey Medical Center.

Did this study involve medication?

Yes. The study involved medication, including Prazosin and Placebo.

Who was this study for?

Listed age limits: 18 years to 45 years.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.